Hemostemix Stock Fundamentals
| HEM Stock | CAD 0.08 0.01 11.11% |
Hemostemix fundamentals help investors to digest information that contributes to Hemostemix's financial success or failures. It also enables traders to predict the movement of Hemostemix Stock. The fundamental analysis module provides a way to measure Hemostemix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hemostemix stock.
At this time, Hemostemix's Interest Expense is fairly stable compared to the past year. Selling And Marketing Expenses is likely to climb to about 1.9 M in 2024, whereas Depreciation And Amortization is likely to drop 211.85 in 2024. Hemostemix | Select Account or Indicator |
Hemostemix Company Shares Outstanding Analysis
Hemostemix's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Hemostemix Shares Outstanding | 123.98 M |
Most of Hemostemix's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hemostemix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Hemostemix Shares Outstanding Driver Correlations
Understanding the fundamental principles of building solid financial models for Hemostemix is extremely important. It helps to project a fair market value of Hemostemix Stock properly, considering its historical fundamentals such as Shares Outstanding. Since Hemostemix's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Hemostemix's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Hemostemix's interrelated accounts and indicators.
Click cells to compare fundamentals
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Hemostemix Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, Hemostemix has 123.98 M of shares currently outstending. This is 31.33% lower than that of the Biotechnology sector and 16.02% higher than that of the Health Care industry. The shares outstanding for all Canada stocks is 78.32% higher than that of the company.
Hemostemix Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Hemostemix's current stock value. Our valuation model uses many indicators to compare Hemostemix value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Hemostemix competition to find correlations between indicators driving Hemostemix's intrinsic value. More Info.Hemostemix is one of the top stocks in return on asset category among its peers. It also is rated as one of the top companies in current valuation category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Hemostemix's earnings, one of the primary drivers of an investment's value.Hemostemix Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hemostemix's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Hemostemix could also be used in its relative valuation, which is a method of valuing Hemostemix by comparing valuation metrics of similar companies.Hemostemix is currently under evaluation in shares outstanding category among its peers.
Hemostemix Fundamentals
| Return On Asset | -3.49 | ||||
| Current Valuation | 15.05 M | ||||
| Shares Outstanding | 123.98 M | ||||
| Shares Owned By Insiders | 9.54 % | ||||
| Number Of Shares Shorted | 11.93 K | ||||
| Price To Earning | (1.70) X | ||||
| Price To Book | 27.76 X | ||||
| EBITDA | (2.16 M) | ||||
| Net Income | (2.5 M) | ||||
| Cash And Equivalents | 49.36 K | ||||
| Total Debt | 4.32 M | ||||
| Current Ratio | 0.05 X | ||||
| Book Value Per Share | (0.1) X | ||||
| Cash Flow From Operations | (1.5 M) | ||||
| Short Ratio | 0.17 X | ||||
| Earnings Per Share | (0.02) X | ||||
| Target Price | 0.96 | ||||
| Beta | 0.19 | ||||
| Market Capitalization | 11.16 M | ||||
| Total Asset | 313.76 K | ||||
| Retained Earnings | (63.27 M) | ||||
| Working Capital | (2.56 M) | ||||
| Net Asset | 313.76 K |
About Hemostemix Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hemostemix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hemostemix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hemostemix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | -2.9 M | -2.8 M | |
| Cost Of Revenue | 223.00 | 211.85 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Hemostemix Stock Analysis
When running Hemostemix's price analysis, check to measure Hemostemix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemostemix is operating at the current time. Most of Hemostemix's value examination focuses on studying past and present price action to predict the probability of Hemostemix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemostemix's price. Additionally, you may evaluate how the addition of Hemostemix to your portfolios can decrease your overall portfolio volatility.